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ABSTRACT Factor Va is an essential protein cofactor of the enzyme factor Xa, which activates prothrombin to thrombin
during blood coagulation. Peptides with an apparent Mr of -94,000 (heavy chain; HC) and -74,000 or 72,000 (light chain; LC)
interact in the presence of Ca2+ to form active Va. The two forms of Va-LC differ in their carboxyl-terminal C2 domain. Using
Va reconstituted with either LC form, we examined the effects of the two LC species on membrane binding and on the activity
of membrane-bound Va. We found that 1) Va composed of the 72,000 LC bound only slightly more tightly to membranes
composed of a mixture of neutral and acidic lipids, the Kd being reduced by a factor of -3 at 5 mM and by a factor of 6 at
2 mM Ca2+. 2) The two forms of Va seemed to undergo different conformational changes when bound to a membrane. 3) The
activity of bovine Va varied somewhat with LC species, the difference being greatest at limiting Xa concentration. We have also
addressed the role of the two Va peptides in membrane lipid rearrangements and binding: 1) Va binding increased lateral
packing density in mixed neutral/acidic lipid membranes. In the solid phase, Va-HC had no effect, whereas Va-LC and whole
Va had similar but small effects. In the fluid phase, Va-HC and whole Va both altered membrane packing, with Va-HC having
the largest effect. 2) Va-HC bound reversibly and in a Ca2+-independent fashion to membranes composed of neutral
phospholipid (Kd 0.3 ,M; stoichiometry 91). High ionic strength had little effect on binding. 3) The substantial effect of
Va on packing within neutral phospholipid membranes was mimicked by Va-HC. 4) Based on measurements of membrane
phase behavior, binding of Va or its peptide components did not induce thermodynamically discernible lateral membrane
domains. These results suggest that the membrane association of factor Va is a complex process involving both chains of Va,
changes in lipid packing, and changes in protein structure.
INTRODUCTION
Factor Vag a nonenzymatic protein cofactor, is apparently
responsible for mediating several of the protein-protein and
protein-membrane interactions required for assembly and
functioning of the prothrombinase enzyme complex. This
enzyme is required for rapid conversion of prothrombin to
thrombin in the blood coagulation cascade. Factor V, which
is a single-chain precursor of factor Va, is hydrolyzed to the
active factor Va by thrombin (Esmon, 1979) or by factor Xa
when little or no thrombin is present (Foster et al., 1984).
Factor Va is composed of peptides with an apparent Mr of
-94,000 (heavy chain; HC) and -74,000 (light chain; LC),
which associate noncovalently in solution in the presence of
Ca2+ ions (Esmon, 1979; Nesheim and Mann, 1979), and
may be dissociated, separated, and then reassociated to full
activity by the addition of divalent metal ions (Esmon,
1979; Krishnaswamy et al., 1989). In vitro activation of
bovine factor V with thrombin results in two forms of light
chain (Mr -74,000 and 72,000), as observed on a polyacryl-
amide gel. These can be separated by ion-exchange chro-
matography with a Mono S column (Guinto and Esmon,
1984; Odegaard and Mann, 1987). The difference between
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these two forms has been attributed to differences in post-
translational glycosylation of the second C-type domain of
human factor Va light chain (Ortel et al., 1992, 1994).
Recently it has been reported (Rosing et al., 1993) that the
two forms of human factor Va have different cofactor ac-
tivities due to differences in their binding affinities to pro-
coagulant membranes.
By virtue of its high-affinity binding to cell (Tracy et al.,
1981; Kane and Majerus, 1982) and phospholipid mem-
branes (Pusey et al., 1982; Krishnaswamy and Mann, 1988;
Kop et al., 1989), factor Va constitutes at least part of the
receptor for factor Xa at the membrane surface (Tracy and
Mann, 1983). The functional factor Va-phospholipid inter-
action is Ca2+ independent and requires anionic phospho-
lipid (Bloom et al., 1979). The binding of factor Va to the
platelet membrane (Tracy and Mann, 1983) and to acidic-
lipid-containing synthetic membranes (Krishnaswamy and
Mann, 1988) is reported to be mediated through the light
chain, and seems to involve both hydrophobic and electro-
static interactions with the membrane surface (Kalafatis et
al., 1990, 1994; Ortel et al., 1992; Lecompte et al., 1994). It
is reported that the heavy chain portion of factor Va is not
directly involved in the interaction of factor Va with mem-
branes (Krishnaswamy and Mann, 1988; Kalafatis et al.,
1994). Binding of factor Va has generally been acknowl-
edged to require acidic lipids in the target membrane. How-
ever, we have reported recently that factor Va binds to
neutral lipid membranes with a Kd of -3.0 ,uM (Koppaka
and Lentz, 1996) and have suggested further that binding of
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this protein to membranes is a complex process involving
acidic-lipid-independent and acidic-lipid-dependent interac-
tions associated with hitherto undetected conformational
changes in factor Va (Cutsforth et al., 1996).
In this study, we have had two main objectives. Our first
objective was to determine differences between the two
forms of light chain with respect to formation of an active
bovine factor Va-membrane complex. The 72-kDa form of
human factor Va light chain is reported to form a factor Va
species that binds 45 times tighter to membranes containing
anionic phospholipids than does factor Va containing the
74-kDa form of light chain (Rosing et al., 1993). However,
most studies of factor Va structure and binding have been
performed with the bovine protein (Higgens and Mann,
1983; Pusey and Nelsestuen, 1984; Isaacs et al., 1986; Kop
et al., 1989; Mosesson et al., 1990; Giesen et al., 1991;
Lecompte et al., 1994), and a large difference between
bovine factor Va samples reconstituted with the two light
chain species was not found. Our second objective was to
examine the interaction of factor Va and its components
with, and their effects on, lipid bilayer membranes. Thereby
we hoped to assess the roles of heavy and light chains in the
formation of a membrane complex. Our results provide two
significant new insights into this process. First, membrane
association appears to involve both chains of the cofactor,
with the heavy chain especially able to associate with neu-
tral lipid membranes. Second, the association of factor Va
with membranes appears not to cause the lateral rearrange-
ment of lipids into acidic lipid domains, in contrast to
previous reports (Mayer and Nelsestuen, 1983), but does
invoke changes in membrane packing that, in the case of
fluid membranes, are mimicked by the heavy chain alone.
EXPERIMENTAL PROCEDURES
Materials
['4C]DMPC was purchased from Amersham (Arlington Heights, IL). 1,2-
Dipentadecanoyl-3-sn-phosphatidylglycerol (DC15PG), 1,2-dimyristoyl-3-
sn-phosphatidylserine (DMPS), 1,2-dimyristoyl-3-sn-phosphatidylcholine
(DMPC), 1,2-dioleoyl-3sn-phosphatidylcholine (DOPC), 1,2-dioleoyl-3-
sn-phosphatidylserine (DOPS), bovine phosphatidylserine (Bov PS), 1-
palmitoyl-2-oleoyl-phosphatidylcholine (POPC), and N-(lissamine rhoda-
mine B sulfonyl)diacyl phosphatidylethanolamine (Rh-PE) were purchased
from Avanti Polar Lipids (Birmingham, AL) and shown to be greater than
98% pure by thin-layer chromatography (Lentz et al., 1982). Solvents were
low-residue, HPLC grade. Concentrations of the stock solutions of the
phospholipids were established by inorganic phosphate determination
(Chen et al., 1956). Phospholipid vesicles were prepared by procedures
similar to that described earlier (Tendian and Lentz, 1990; Koppaka and
Lentz, 1996). Dansylarginine-N-(3-ethyl-1,5-pentanediyl)amide (DAPA)
was synthesized and purified by the procedure of Mann et al. (1981) and
Nesheim et al. (1979b). 1,6-Diphenyl-1,3,5-hexatriene (DPH) was pur-
chased from Molecular Probes (Junction City, OR). All other chemicals
were reagent grade or better.
Bovine prothrombin and factor X were purified from a BaSO4 adsorbate
of 12 liters of bovine plasma (Lentz et al., 1994). Factor X was activated
with a purified fraction of Russel's viper venom factor X-activating protein
(Hematologic Technologies, Essex Junction, VT), which had been co-
valently linked to agarose beads (Jesty and Nemerson, 1976). Purification
performed by the procedure of Esmon (1979). Further purification of the
factor Va components and subsequent labeling of factor Va heavy chain
with fluorescein maleimide was carried out as described earlier (Koppaka
and Lentz, 1996). The two forms of factor Va were also purified directly
from activated factor V by separation on a Mono-S column, using a NH4Cl
gradient (Rosing et al., 1993). In this procedure, factor Va with the light
chain of Mr -74,000 eluted first and the Va containing the light chain of
Mr -72,000 eluted later. The final purity of the proteins was ascertained by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
to be greater than 90%. Factor Va or its component peptides were precip-
itated by the addition of solid ammonium sulfate to 80% saturation,
collected by centrifugation (Beckman TL-100, 25 min, 30,000 rpm, 4°C),
resuspended in 20 mM N-[Tris(hydroxymethyl)methyl]-2-aminoethanesul-
fonic acid (TES), 5 mM CaCl, 50% (v/v) glycerol (pH 7.4), and stored at
-200C.
Protein concentrations were determined by absorbance measurements
using extinction coefficients at 280 nm, corrected for solution scattering
(Donovan, 1969). The molecular weights and extinction coefficients
(E28 g'/ml) used for the proteins were: factor V, 330,000, 0.96; factor Va,
150,000, 1.74; factor Va light chain, 74,000, 2.23; factor Va heavy chain,
94,000, 1.24 (Nesheim et al., 1981); prothrombin, 72,000, 1.44 (Mann,
1976); factor Xa, 45,000, 0.94 (Jesty and Nemerson, 1976).
Reconstitution of factor Va
A solution containing a mixture of 2.0 ,uM light chain and 2.4 ,uM heavy
chain was incubated for 1.5 h at 37°C in 20 mM TES, 150 mM NaCl (pH
7.4) containing 5 mM CaCl2. The assay for activity of reconstituted factor
Va involved direct measurement of prothrombin activation catalyzed by
prothrombinase, using the fluorescent a-thrombin inhibitor DAPA
(Nesheim et al., 1981) to directly monitor thrombin formation in an SLM
48000 spectrofluorometer (SLM Aminco, Urbana, IL) with an excitation
wavelength of 335 nm (slits at 8 nm) and a Schott KV 515 (Schott Glass
Technologies, Durea, PA) cutoff filter in the emission path. In these
measurements, cuvettes (1.0 ml) contained 1.4 ,uM prothrombin, 20 ,uM
bov PS/POPC (25/5) vesicles, and 3.0 ,LM DAPA in 20 mM TES, 0.15 M
NaCl, 5 mM CaCl2 (pH 7.4). The reaction mixtures were equilibrated for
10 min at 22°C under constant stirring. Aliquots of reassociated factor Va
(nominal concentration of 1 nM) incubated at the appropriate temperature
were added to the reaction mixture. Proteolysis of prothrombin was then
initiated by the addition of factor Xa to a final concentration of 10 nM.
Initial rates of prothrombin activation were calculated from the initial,
steady-state portion of the resulting continuous progress curves and were
converted to units describing molar thrombin produced per unit time by
assuming that fluorescence intensity at infinite time represented the quan-
titative conversion of prothrombin to thrombin (Krishnaswamy et al.,
1989).
Kinetic measurement with DAPA
Experiments involving prothrombin activation as a function of phospho-
lipid concentration were carried out as described earlier (Pei et al., 1993).
These measurements were carried out at 37°C on a Shimadzu RF5000
fluorescence spectrophotometer (Shimadzu Corp., Kyoto, Japan), with
excitation at 280 nm (band pass 5 nm) and emission at 540 nm (band pass
5 nm). All buffers were filtered through a 0.45-,um filter (Alltech, Deer-
field, IL) to reduce scattered light artifacts. Two sets of experiments were
carried out with varying phospholipid concentrations. The reaction mixture
(1.0 ml in a continuously stirred cuvette) in set A (limiting factor Va)
contained 20 mM Tris, 0.15 M NaCl (pH 7.4), 5 mM CaCl2, 1.2 nM Xa,
0.2 nM Va, 500 nM DAPA, and variable concentrations of the phospholipid
mixture. In set B (limiting factor Xa), the reaction mixture contained 0.1
nM Xa, 1.2 nM Va, 500 nM DAPA, and varying concentrations of the
phospholipid. The reaction mixtures were equilibrated for 3 min, allowing
the prothrombinase to be fully assembled before initiating proteolysis by
of factor V and its heavy and light chain components after activation was
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used a low concentration of prothrombin to avoid having the substrate
compete with the two forms of Va for the membrane and thus interfere with
the sensitivity of the assay for detecting any difference in the activities of
the two forms of factor Va. Rates of change of fluorescence intensity with
time were converted into units of active site formation per unit time per
unit of hypothetical membrane-bound factor Xa-Va complex (Pei et al.,
1993), using the long-time fluorescence and the known concentration of
prothrombin to estimate the change in fluorescence intensity per mole of
thrombin formed. The initial slopes for all of the titrations were determined
when less then 15% of the substrate had been consumed, thus avoiding the
problem of substrate depletion.
Fluorescence anisotropy measurements
In an earlier paper, we used three different probes (two lipid-associated and
one protein-associated) to characterize the interaction of factor Va with
phosphatidylcholine membranes (Koppaka and Lentz, 1996). In five dif-
ferent types of binding experiments, all gave consistent results. Here we
focus on two of these probes (protein-associated fluorescein and mem-
brane-associated DPH) to characterize further the association of factor Va
with membranes. For measurements with DPH-labeled membranes, a small
volume (-1.5 ,ul) of a stock solution of DPH (0.332 mM) in acetone was
added to small unilamellar vesicle (SUV) suspensions to achieve a final
dye:lipid ratio of 1:150. The vesicles were then vortexed thoroughly and
incubated for 1 h at 40°C before use to achieve maximum partitioning of
DPH into the bilayer. DPH-containing vesicles were added to a stirred
microcuvette (Helma Cells, Jamaica, NY) containing buffer (20 mM TES,
150 mM NaCl, 5 mM CaCl2, pH 7.4) and protein. The final volume in the
cuvette was 1 ml, and the final concentration of phospholipid was 15 ,uM.
The added protein was adjusted so that there was enough protein in a
vesicle suspension to saturate the lipid surface-binding sites to better than
95% at every lipid composition. The ratio of protein concentration to lipid
concentration used in these experiments was chosen on the basis of
previously determined protein binding constants (Krishnaswamy and
Mann, 1988; Cutsforth et al., 1996) to achieve this level of binding site
saturation.
The mixture in the cuvette was allowed to incubate at 450C for 10-15
min before the fluorescence measurements were begun during a cooling
scan. The cuvette temperature, was maintained with a programmable
Neslab RTE-8 water bath equipped with an ETP-3 programmer (Neslab
Instruments, Portsmouth, NH) and continuously monitored with a model
5810 Digitec digital thermometer and a model 702A Yellow Springs
Instrument probe (Yellow Springs, OH) inserted directly into the cuvette.
Measurements of DPH fluorescence anisotropy were made with an SLM
48000 spectrofluorometer, using an excitation wavelength of 366 nm.
Emission was detected in T-format rough 418-nm cutoff filters. Anisotropy
measurements were taken every 0.2°C at scan rates of 30°C/h. Details and
interpretations of these measurements are discussed elsewhere (Lentz et al.,
1976a,b; Tendian and Lentz, 1990).
Generation of binding isotherms
For the measurements with reconstituted fluorescein-labeled factor Va and
fluorescein-labeled factor Va-heavy chain, an excitation wavelength of 490
nm was used. Excitation slits were 8 and 4 nm, respectively, and 500-nm
cutoff filters were used in the emission path in a T-format. Measurements
were performed at 23°C. Aliquots of SUV were added to the cuvette
containing the labeled factor Va in 20 mM TES, 150 mM NaCl (pH 7.5)
and an appropriate concentration of CaCl2. The sample was stirred after
each addition for 2 min, and readings were taken 45 s after the stirring was
stopped. Correction for light scatter of vesicles was made by measuring and
subtracting from the observed values the parallel and perpendicular com-
ponents of intensity due to vesicles alone.
The binding parameters were determined according to the following
equation (Krishnaswamy et al., 1986):
robs = ro + (rma - r.) P[pb (1)
where rObS, r., and rm, are the observed, initial, and maximum anisotropy
values corresponding to the protein that is all unbound, partially bound, or
all bound to membranes, respectively. [P]b and [P]T are the concentrations
of the bound and total protein concentrations. The concentration of bound
protein, [P]b, is given by
[P]b =
([PL]T ' i + [P]T + Kd)
- U(P]T + [PL]T* i + Kd)2 - (4 * [P]T* [PL]T* i)
2
(2)
where Kd is the equilibrium dissociation constant, 1/i is the stoichiometry
in moles of lipid monomer per mole of protein, and [PLUT is the total
phospholipid concentration.
Fluorescence energy transfer experiments using fluorescein-labeled fac-
tor Va heavy chain were carried out as described previously for labeled
factor V. (Koppaka and Lentz, 1996). An excitation wavelength of 470 nm
and slits of 8 and 4 nm were used. Donor (fluorescein) emission was
recorded at 520 nm through slits of 4 and 8 nm to monitor energy transfer
to Rh-PE (acceptor). Aliquots of SUVs of POPC containing 1% Rh-PE
were added to a microcuvette containing fluorescein-labeled factor V.-
heavy chain in 20 mM TES, 150 mM NaCl, 5 mM CaCl2 (pH 7.5). The
cuvette contents were constantly stirred, and, after an equilibration time of
2 min, emission was recorded. Corrections for dilution were made by the
addition of unlabeled vesicles to the donor.
As described elsewhere (Koppaka and Lentz, 1996), the analysis of the
binding data obtained from resonance energy transfer experiments involves
a complication in that Fd/Fd, the ratio of the fluorescence efficiencies of
the donor in the absence and the presence of acceptor, continues to increase
in a linear fashion, even after binding is saturated. This linear increase is
due simply to the increase in the probability of transfer associated with
higher acceptor concentration. The data were thus fit with the following
equation:
Fd
a
= I +
Fda
[/Fd lPb
da -1I-[I +m 4PL]T (3)
where the first term accounts for binding, with [P]b given by Eq. 2, and the
second term accounts for transfer between acceptor and donor that are not
bound to each other. The binding parameter values were obtained by a
global analysis as described above. The value of m was estimated in two
ways. First, m was taken as the slope of the binding curve at high
concentrations of the phospholipid, and then constrained during regression
analysis. Second, m was allowed to vary during regression analysis and
estimated along with the binding parameters. In both cases, m was found to
be similar, and the binding parameters were independent of the way in
which the value of m was determined.
Finally, binding was also monitored by the change in the average
hydrodynamic SUV radius as protein bound to the vesicle. POPC SUVs
suspended (0.2 mM) in 150 mM NaCl, 5 mM CaC12, and 20mM TES (pH
7.5) were sized at 22°C by quasielastic light scattering (QELS) in a
home-built light-scattering photometer equipped with a Nicomp model 170
computing autocorrelator (Particle Sizing Systems, Santa Barbara, CA), as
described in detail elsewhere (Lentz et al., 1992). To this suspension were
added small aliquots (-5 p.l) of Va-HC (9 ,uM). After gentle mixing,
samples were allowed to equilibrate for 6-8 min, and then were sized
again. A single Gaussian was adequate to describe the distribution of
vesicle diameters, except at high (>0.45 ,uM) Va-HC concentration, where
aggregation became evident. After correcting for the dilution of the original
SUV suspension due to added volume, the observed vesicle diameters (D)
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were fit to the equation described by Koppaka and Lentz (1996):
(Dmax - D0)/[] Kd
Dobs Do + 2[PL] [PL]T +
(Dmax- DO)
2' [PL]T
+ [PL]T + )2 (4 * (P]T . [PL]T))
(4)
The binding parameter values, Kd and i, were set as global parameters,
whereas the maximum observables (rm., [Fd/Fda]max, and Dmax) were set
as local parameters during a global analysis of multiple data sets (Koppaka
and Lentz, 1996). For studies of factor Va binding to PS/PC membranes,
multiple data sets were fit using the SCoP package (Simulation Control
Program; Simulation Resources, Berrien Spring, MI). Single data sets were
analyzed with the same program. For studies of Va-HC binding to POPC
SUVs, SCoP was used to fit simultaneously all three types of binding
experiment: fluorescence anisotropy, energy transfer, and vesicle diameter.
RESULTS
Activity of the two forms of factor Va
Factor Va components were purified from activated factor V
as described earlier (Koppaka and Lentz, 1996). All exper-
iments were performed using either the purified components
of factor Va or factor Va reconstituted from the purified
components. The two forms of factor Va were also separated
via a Mono-S column (Rosing et al., 1993). The SDS-PAGE
gel shown in Fig. 1 demonstrates the purity of the two forms
of factor Va separated via a Mono-S column and of the
components of factor Va isolated from activated factor V
(Koppaka and Lentz, 1996). Densitometry measurements
indicated that the procedure for separation of the two forms
of factor Va yielded nearly 95% pure protein for factor Va
with the Mr -72,000 light chain and 85% pure protein for
the factor Va with the Mr -74,000 light chain. The purified
components yielded 72,000 light chain, 74,000 light chain,
and heavy chain of 90%, 95%, 85% purity, respectively.
Because we wanted to fluorescently label the heavy chain
alone instead of whole factor Va, we have used reconstituted
factor Va for all of our experiments. The activities of the two
forms of factor Va, whether isolated directly or reconstituted
from its individual components, were similar under the
conditions of our standard factor Va assay (Experimental
Procedures).
Activity of reconstituted factor Va preparations was nor-
mally determined using the DAPA assay at 22°C, under
conditions of excess factor Va and limiting factor Va, as
described in the Experimental Procedures. Identical pro-
thrombinase activities were observed for the two forms of
factor Va reconstituted from the 94,000 molecular weight
(MW) heavy chain combined with the 74,000 (1.14 ± 0.08
,uMIIa/minNa) and 72,000 (1.23 ± 0.08 jLMIIa/minNa)
MW light chains. These activities agreed well with the
activity of factor Va reconstituted from immunopurified
1 2 3 4 5
heavy chain
(94,000) -----
light chains
(74,000)
(72,000)
FIGURE 1 SDS-polyacrylamide gel electrophoresis of factor Va. Puri-
fied factor Va and components were subjected to SDS-PAGE containing
8% acrylamide and stained with Coomassie blue. About 2-2.5 ,ug of
protein was loaded into each well. Lane 1, factor Va (94,000 HC and
72,000 LC) separated by Mono-S; Lane 2, factor Va (94,000 HC and
74,000 LC) separated by Mono-S; Lane 3, 72,000 light chain; Lane 4,
74,000 light chain; Lane 5, factor Va-heavy chain.
subunits (1.27 ± 0.05 IiMIIa/minNa; Krishnaswamy et al.,
1989). However, it has been pointed out (Rosing et al.,
1993) that assays carried out at limiting concentrations of
factor Va might not detect differences between the two
forms of factor Va. For this reason, experiments were also
carried out to characterize the activity of the two types of
factor Va by varying the concentrations of phospholipid
(25/5 PS/POPC) under conditions for which either 1) the
cofactor or 2) the enzyme concentrations were limiting. The
initial velocities of prothrombin activation for both forms of
factor Va are given in Fig. 2 A as a function of phospholipid
concentration under conditions for which the concentration
of factor Va was limiting. It was observed, as reported
earlier (Pei et al., 1993), that a minimal or critical phospho-
lipid concentration was required to observe significant rates
of thrombin formation. At lipid concentrations just above
this critical concentration, the activities of both forms of Va
were essentially identical. However, at higher concentra-
tions of phospholipid (-0.5-10 ,uM), factor Va reconsti-
tuted from the 72,000 MW form of the light chain was
found to be slightly more active. Experiments using an
excess of factor Va and a limiting concentration of factor Xa
showed a similar behavior (Fig. 2 B) in that the 72,000MW
form was found to be increasingly more active at higher
phospholipid concentrations. However, the enhanced activ-
ity of the 72,000 MW relative to the 74,000MW light chain
forms of factor Va was noted, even at low phospholipid
concentrations, and was dramatic at high phospholipid con-
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FIGURE 2 Dependence of the initial velocity of prothrombin activation
on the concentration of phospholipid. Values of the initial velocity were
determined from the slopes of time courses of prothrombin active site
development, continuously monitored with the fluorescent thrombin inhib-
itor DAPA. Data are shown for factor Va reconstituted using the 74,000 (0)
and 72,000 ([) forms of light chain. The reactions were initiated by the
addition of prothrombin (50 nM) to a solution of (A) 1.2 nM factor Xa, 0.2
nM factor Va or (B) 0.2 nM factor Xa, 1.2 nM factor Va with 500 nM
DAPA and varying concentrations of phospholipid (25:75 Bov PS:POPC)
in 20 mM Tris, 150 mM NaCl, 5 mM CaC12 (pH 7.4) at 37°C.
centrations under conditions of limiting factor Xa concen-
tration, as demonstrated in Fig. 2 B.
Interaction of the two forms of factor Va
with membranes
The change in anisotropy of fluorescein-labeled reconsti-
tuted factor Va as a function of increasing concentrations of
bovine PS/POPC (25:75) SUV at 5 mM and 2 mM calcium
are given in Fig. 3, A and B, respectively. Both curves
showed a well-defined saturation behavior of the anisotropy
at a high concentration of vesicles. The binding parameters
describing these curves (dissociation constant Kd, stoichi-
ometry n, and change in saturating anisotropy, Arsat) were
obtained by nonlinear, least-squares regression analysis (see
Experimenatl Procedures); these are given in Table 1. A
FIGURE 3 Titration of fluorescein-labeled factor Va with phospholipid
vesicles. Effect of increasing concentrations of Bov PS/POPC (25/75)
SUVs on the fluorescence anisotropy of fluorescein-labeled factor V.
composed of the 72,000 light chain (-) and the 74,000 light chain (0) at
(A) 5 mM Ca2' and (B) 2 mM Ca2+. The initial concentration of Va was
0.1 ,uM in 20 mM TES, 150 mM NaCl (pH 7.5) with appropriate calcium
concentrations.
global analysis for determining the binding parameters was
used when there was more than one set of data in an
experiment (Table 1). The parameters describing binding of
the 72,000 MW species are consistent with those reported
previously for the binding of unfractionated pyrene-labeled
factor Va (Kd = 2 nM at 4 mM Ca2+; Cutsforth et al., 1996).
It is evident from the data and from these parameters that
the binding of the 72,000 MW light chain factor Va to both
bovPS/POPC and DOPS/DOPC SUV was only slightly
tighter than that of the 74,000 MW light chain form (Kd
related by a factor of less than 3) at 5 mM Ca2+. Binding of
both species was somewhat tighter to membranes contain-
ing the more unsaturated bov PS species. Of particular note,
the values of Arsat, which reflect the conformational state of
the bound protein (Cutsforth et al., 1996), were clearly
different at 5 mM Ca2+ for the two forms of factor Va,
suggesting that the two forms assume somewhat different
conformations on membranes of optimal PS content
(Cutsforth et al., 1996). Although the 72,000 and 74,000
MW light chains were of slightly different purity (90 versus
95%), it is not likely that the difference in Arsat reflects a
difference in the amount of uncomplexed heavy chain in the
two samples, since reconstitution was always performed
with a slight molar excess of labeled heavy chain and
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TABLE I Binding parameters of the two forms of factor V8
Factor Va Phospholipid No.* Kd (nM)# n Arsat
5 mM Ca2+
72,000 BovPS/POPC(25n5) (2) 3.9 ± 1.8 69 ± 24 0.026 ± 0.008
74,000 BovPS/POPC(25n5) (2) 11.0 ± 1.3 90 ± 18 0.014 ± 0.004
72,000 DOPS/DOPC(20/80) (1) 8.7 ± 0.5 53 ± 9 0.023 ± 0.009
74,000 DOPS/DOPC(20/80) (1) 28.5 ± 1.8 48 ± 14 0.014 ± 0.003
2 mM Ca2+
72,000 BovPS/POPC(25/75) (2) 6.1 ± 2.0 63 ± 20 0.015 ± 0.003
74,000 BovPS/POPC(25n5) (2) 32.5 ± 3.8 71 ± 23 0.013 ± 0.004
72,000 DOPS/DOPC(20/80) (2) 5.58 ± 2.1 61 ± 19 0.025 ± 0.003
74,000 DOPS/DOPC(20/80) (2) 40.9 ± 9.0 45 ± 8 0.019 ± 0.006
*The number of data sets in experiments done under each condition.
#Kd and n are the dissociation constants and the stoichiometry of the number of phospholipid molecules per protein, obtained by adjusting both parameters
as global variables and the values of Arsat([rmax - ro] in Eq. 1) as local variables. Uncertainties in parameter values are given as the standard deviations
in the best fit parameters.
because the difference in Arsat was not observed at 2 mM
c2+.Ca2~
At 2 mM Ca2+, the enhanced binding of the 72,000 MW
relative to the 74,000 MW light chain form of factor Va to
PS-containing membranes was even clearer (Kd values dif-
fered by a ratio of -6 in Table 1). Unlike at 5 mM Ca2 ,
there was also no significant difference between data ob-
tained with SUVs composed of bov PS/POPC (25/75) ver-
sus DOPS/DOPC (20/80). Also unlike the behavior at 5 mM
Ca2+, there was no significant difference between Arsat
values observed for the two factor Va species. Thus the
detailed events leading to formation of a factor Va-mem-
brane complex are Ca2+-concentration dependent.
Effect of factor V. and its polypeptide
constituents on membranes
Temperature dependence of factor Va activity
Our second objective was to examine the interaction of
factor Va and its two peptide components with membrane
bilayers. First we asked whether factor Va or its components
altered the lipid packing or lateral distribution of acidic and
neutral lipids in the plane of the membrane. Our approach
was to use a membrane probe to monitor the temperature
dependence of lipid packing order and to use this informa-
tion to construct membrane phase diagrams as a function of
acidic lipid content in the presence of factor Va and its
components. To do this, it was necessary to know the effect
of temperature on the activity of factor Va. This is docu-
mented in Fig. 4. The data are plotted as a percentage of
activity, taking activity at 22°C (see above) as 100%. Factor
Va activity decreased from 22°C to 30'C, remained roughly
constant from 30°C to 46°C, and then decreased dramati-
cally from 46°C to 55°C. For this reason, samples for
membrane phase behavior measurements were maintained
at or below 45°C.
Pure DMPC vesicles
The phase behavior of pure DMPC vesicles in the presence
and absence of factor Va and its constituents was studied by
monitoring the temperature dependence of the fluorescence
anisotropy of DPH. This is an established method for de-
tecting lipid phase transitions in the absence and presence of
proteins (Lentz et al., 1976a,b; Tendian and Lentz, 1990). In
addition, changes in the fluorescence anisotropy of this
hydrophobic probe serve as an indicator of changes in
membrane order due to interaction of a protein with the
membrane bilayer (Tendian and Lentz, 1990). Fig. 5 shows
the fluorescence anisotropy of DPH incorporated into
DMPC small unilamellar vesicles recorded during cooling
of vesicles in the presence of factor Va (empty triangles),
factor Va light chain (filled circles), heavy chain (filled
triangles), and in the absence of protein (empty circles). All
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FIGURE 4 Temperature dependence of factor Va activity. Factor Va was
reconstituted by incubating a mixture containing 0.12 ,uM light chain and
0.35 ,uM heavy chain in 20 mM Tris, 150 mM NaCl, 5 mM CaCl2 (pH 7.4)
at 37°C for 1.5 h. Aliquots were withdrawn, maintained at the indicated
temperatures for 10 min, and assayed for activity at 22°C, using the DAPA
assay under conditions of limiting factor Va (Nesheim et al., 1981).
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FIGURE 5 Phase transitions of DMPC vesicles as monitored by DPH
fluorescence anisotropy. DPH fluorescence anisotropy was measured as
described under Experimental Procedures for vesicles alone (0), vesicles
in the presence of a native mixture of factor Va species (A), vesicles in the
presence of factor Va light chain (also a native mixture; E]), and vesicles
in the presence of factor Va heavy chain (V). The probe-to-lipid mol ratio
was 1:150. The phospholipid concentration in all experiments was 15 J,M.
The final concentration of factor Va and its light chain was 0.5 ,M, and the
heavy chain concentration was 0.6 ,LM in 20 mM TES, 150 mM NaCl, 5
mM CaCl2 (pH 7.4).
curves show a dramatic decrease in the anisotropy associ-
ated with the main DMPC phase transition occurring at
-24.3°C. Neither factor Va nor its components altered the
phase behavior ofDMPC membranes; i.e., neither factor Va
nor its components altered the shape of the phase transition
or its temperature range (horizontal position of the curves).
Both factor Va and its heavy chain caused comparable
increases in DPH fluorescence anisotropy over the entire
temperature range, but especially in the fluid phase, com-
pared to vesicles without protein (Fig. 5). Table 2 summa-
rizes these observations in terms of the fluorescence anisot-
ropy shifts caused by factor Va or its heavy chain at
temperatures of 5°C above and below the phase boundaries
of DMPC SUV. Because these proteins did not shift the
phase transition, the observed increase in anisotropy was not
due to changes in the physical state of the membrane. This
indicates that these proteins interacted with the vesicles and
promoted increased lateral packing density in both the fluid
and solid phases of the membrane, but especially in the fluid
phase. The light chain did not cause any significant change
in DPH anisotropy, in either fluid or solid phase vesicles
(Fig. 5, filled circles; Table 2). Taken together, these ob-
servations suggest an interaction of factor Va with DMPC
membranes and that this interaction occurs mainly through
the factor Va heavy chain rather than through the light chain.
Several observations indicate that the observed shifts in
DPH fluorescence anisotropy reflect changes in membrane
structure due to protein binding rather than partitioning of
DPH into the protein. In control experiments performed in
the absence of lipid, we observed a sevenfold increase in
DPH fluorescence intensity in the presence of factor Va but
no change in fluorescence anisotropy (0.008 ± 0.006 ->
0.002 ± 0.004). In contrast, there was a 34-fold increase in
intensity accompanied by a significant increase in anisot-
ropy (0.008 -> 0.128) in the presence of POPC SUVs.
Factor Va heavy chain did cause an increase in DPH anisot-
ropy (0.172) but an insignificant increase in intensity (1.8-
fold). In both cases, the combination of either no anisotropy
change and/or insignificant intensity change made it impos-
sible to estimate, by previously described procedures (Lentz
et al., 1976b), the partition coefficient of DPH between the
membrane and protein. However, these observations also
made it clear that the observed fluorescence anisotropy
shifts of DPH in the presence of both lipid and factor Va or
Va heavy chain were due almost exclusively to DPH asso-
ciated with the lipid rather than with the protein component
of a test sample. The fact that DPH accurately detected the
lipid order/disorder phase transition supports this conclu-
sion, as does the observation that the DPH anisotropy shifts
due to factor Va or its heavy chain were different for
different membranes (see below). Thus the increase in DPH
anisotropy observed in the presence of membrane and factor
Va or its heavy chain must be due to the interaction of the
TABLE 2 Summary of effects of factor Va and its heavy and light chain constituents on membranes of different phospholipid
compositions
Aaniso (fluid)II Aaniso (gel)II
Lipid Va Va-LC Va-HC Va Va-LC Va-HC
DMPC 0.040 0.003 0.040 0.017 0.001 0.023
DMPS/DMPC* 0.018§ 0.004§ 0.024# 0.017§ 0.018§ 0.009#
DC15PG/DMPC* 0.008' 0.003' 0.025' 0.006' 0.014' 0.000'
*The values given are the average of the delta fluorescence anisotropy values (lipid plus protein - lipid alone) obtained for membranes composed of varying
DMPS and DC15PG concentrations at 50C above (fluid) or below (gel) the phase boundaries. Values have been obtained by taking an average of two or
five observations.
#These values were determined from data obtained in two sets of experiments at compositions of 26174 DMPS/DMPC and 31/69 DMPS/DMPC.
§These values were determined from data obtained in experiments at compositions of 6/94 DMPS/DMPC, 10/90 DMPS/DMPC, 15/85 DMPS/DMPC, 26/74
DMPS/DMPC, and 31/69 DMPS/DMPC.
1These values were determined from data obtained in experiments at compositions of 30/70 DC15PG/DMPC, 40/60 DC15PG/DMPC, 50/50 DC15PG/DMPC,
58/42 DC15PG/DMPC, and 77/33 DC15PG/DMPC.
I1The reproducibility of anisotropy measurements was ±0.001.
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protein with the membrane and not to binding of DPH to the
protein.
DMPS/DMPC SUVs
To examine the influence of factor Va binding on the
packing and lateral organization of lipids within PS-con-
taining membranes, we monitored the effects of protein
binding on the phase behavior of membranes with varying
acidic lipid contents. The effects of factor Va and its light
and heavy chains on DMPS/DMPC SUVs with three dif-
ferent compositions can be seen from the DPH fluorescence
anisotropy data recorded in Fig. 6. These data show only a
small effect of factor Va binding to DMPS-containing mem-
branes on the phase behavior of these membranes (i.e., on
the shapes or horizontal positions of these curves). Both
factor Va and its light chain slightly raised the temperature
of the gel-phase boundary in these membranes. The pres-
ence of these proteins did not measurably affect the fluid-
phase boundary of the membranes. The failure of factor Va
or its heavy or light chain components to alter the phase
behavior of DMPS/DMPC SUV indicates that binding of
these proteins does not significantly affect the intermixing
of these lipids in the plane of the membrane bilayer.
The effects of factor Va and its heavy and light chain
constituents on the fluorescence anisotropy of DPH incor-
porated into DMPS/DMPC membranes are shown in terms
of average fluorescence anisotropy shifts (averaged over
membranes with different DMPS contents) in Table 2. Fac-
tor Va slightly increased the DPH fluorescence anisotropy
just below the gel and above the liquid-crystalline phase
boundaries of the lipid vesicles. From these data, we con-
clude that factor Va binding stabilized or favored increased
lateral packing of lipids in both the fluid and solid phases of
the membranes. At the gel-phase boundary, factor Va light
chain had effects similar to those of whole factor Va (Table
2), whereas the effect of the heavy chain was less pro-
nounced. In the fluid phase, however, factor Va heavy chain
seemed to have contributed most to the anisotropy shift
induced by whole factor Va, in agreement with the obser-
vations on pure DMPC vesicles (Fig. 5 and Table 2). In
general, however, although factor Va heavy chain had a
pronounced effect on the order within DMPC-containing
membranes, its effects on molecular order within DMPS-
containing vesicles were smaller (Table 2).
DC15PG/DMPC SUVs
Fig. 7 shows the effect of temperature on the fluorescence
anisotropy of DPH in vesicles composed of three different
DC15PG/DMPC ratios in the presence and absence of factor
Va and its components. As for DMPS/DMPC vesicles, there
was little change in the shape or horizontal position of the
anisotropy curves in the presence of factor Va or its com-
ponents. As for DMPS/DMPC vesicles, factor Va and its
light chain slightly raised the temperature of the gel-phase
boundary, but had no clear effect on the temperature of the
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FIGURE 6 Phase transitions of DMPS/DMPC small unilamellar vesicles
of varying DMPS content. (A) 6/94 DMPS/DMPC; (B) 26/4 DMPS/
DMPC; (C) 31/69 DMPS/DMPC. DPH fluorescence anisotropy is plotted
as a function of temperature for vesicles alone (0), vesicles in the presence
of a native mixture of factor Va species (A), vesicles in the presence of
factor Va light chain (also a native mixture; El), and vesicles in the
presence of factor Va heavy chain (V). The final concentration of Va and
factor Va light chain was 1.2 ,uM in A, 0.45 ,LM in B, and 0.5 ,uM in C. The
concentration of the factor Va heavy chain was 0.54 ,uM in B and 0.6 ,uM
in C.
fluid-phase boundary (Fig. 7). Again, these results argue
against protein-induced DC15PG-rich domains associated
with factor Va or Va heavy or light chain binding.
As for DMPS/DMPC vesicles, the average effects of the
proteins on molecular order within various DC15PG/DMPC
membranes are summarized in Table 2. Factor Va produced
only a small increase in DPH fluorescence anisotropy just
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FIGURE 7 Phase transitions of DC 5PG/DMPC small unilamellar vesi-
cles of varying DC15PG content. (A) 30/70 DC15PG/DMPC; (B) 58/42
DC15PG/DMPC; (C) 77/23 DC15PG/DMPC. DPH fluorescence anisotropy
is plotted as a function of temperature for vesicles alone (0), vesicles in the
presence of a native mixture of factor Va species (A), vesicles in the
presence of factor Va light chain (also a native mixture; E), and vesicles
in the presence of factor Va heavy chain (V). The final concentration of Va
and factor Va light chain was 0.6 ,uM in A, 0.25 ,uM in B, and 0.2 ,uM in
C. The concentration of the factor Va heavy chain was 0.72 ,uM in A, 0.3
,uM in B, and 0.24 pLM in C.
above the fluid phase boundary of the membranes and
virtually no effect at the gel phase boundary. Factor Va
heavy chain clearly altered packing in the fluid phase of
both DC15PG/DMPC and DMPS/DMPC vesicles (Table 2),
but had very little effect on packing within the gel phase,
which was altered, however, by the light chain. Interest-
ingly, although factor Va light and heavy chains had similar
effects on DMPS- and DC15PG-containing membranes,
whole factor Va had very little effect on the packing in
DC15PG/DMPC vesicles but did slightly alter the molecular
packing within DMPS/DMPC vesicles. This suggests that
factor Va has different interactions with membranes of
varying acidic lipid compositions, consistent with our pre-
vious observations (Cutsforth et al., 1996).
Measurement of factor V.-heavy chain binding
with neutral lipid membranes
Because our DPH anisotropy measurements indicated that
the effect of factor Va on lipid packing within DMPC
bilayers might be due to the heavy chain component of this
protein, we decided to investigate heavy chain binding to
neutral lipid membranes by direct titration methods (Fig. 8).
The binding of fluorescein-labeled factor Va-heavy chain to
POPC vesicles was monitored by changes in fluorescein
fluorescence anisotropy and by fluorescence energy transfer
from fluorescein-labeled heavy chain to rhodamine-labeled
phospholipid, and the binding of unlabeled Va-HC was
detected by the increase in vesicle hydrodynamic diameter
as protein binds.
A small and saturable increase in the anisotropy of pro-
tein-bound fluorescein was observed with increasing lipid
concentrations (Fig. 8 A). We note that binding of pyrene-
labeled factor Va to neutral membranes produced no change
in anisotropy (Cutsforth et al., 1996) and that binding of
fluorescein-labeled factor Va to neutral membranes also
produced a much smaller change in anisotropy (Arm.a =
0.006) than did binding to acidic-lipid-containing mem-
branes (Arma, = 0.23; Koppaka and Lentz, 1996). Although
the anisotropy changes seen in the presence of neutral lipid
membranes are small, they are not due to aggregation-
induced light-scattering artifacts or to other irreversible
changes in the protein brought about by the presence of
lipid. This is demonstrated by the inset in Fig. 8 A, which
shows the effect of adding unlabeled Va-HC to a sample that
had -63% 0.2 ,.M labeled peptide bound to POPC SUVs.
The fluorescence anisotropy of fluorescein-labeled Va-HC
clearly approaches the value recorded for unbound, labeled
Va-HC (dashed line) as it is competed off of the membrane
by unlabeled protein. We conclude that the increase in
fluorescein fluorescence anisotropy seen upon the addition
of POPC vesicles must be due to protein-membrane inter-
actions, which, we have noted previously (Cutsforth et al.,
1996), cause changes in the segmental flexibility of the
protein-attached probe.
To determine whether ionic composition had a significant
impact on the interaction of Va-HC with neutral lipid mem-
branes, we determined binding isotherms in buffer contain-
ing 25 mM Na2EDTA to complex Ca2+ (filled circles in
Fig. 8 A) or 400 mM (instead of 150 mM) NaCl (filled
triangles in Fig. 8 A). Although the figure illustrates that the
anisotropy shift associated with the membrane-bound state
was sensitive to buffer ionic composition, the binding in-
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(A) Effect of increasinz concentrations of
Because Ca2+ is needed for the interaction of the light and
heavy chains to form active factor Va, it is not surprising
that the segmental flexibility of the bound fluorescein was
altered or even that the Kd is slightly altered in the presence
) of EDTA.
For energy transfer experiments, a clear saturation was
8 - not observed at high concentrations of vesicles (Fig. 8 B).
6- Rather, the quenching of the donor fluorescence became
0.0 0.2 0.4 linear at high acceptor concentrations. We note in the
[HC] (uM) Experimental Procedures (see Eq. 3) that this linear de-
pendence on acceptor concentration is the behavior ex-
B pected for a noninteracting donor-acceptor pair in solution
(Koppaka and Lentz, 1996). The increase seen at low con-
0 centrations of membranes, however, must be due to close
juxtaposition of donor and acceptor fluorophores and, as
such, provides clear evidence of Va-HC binding to POPC
membranes.
As a final measure of Va-HC binding to POPC SUVs, we
monitored by QELS the rate of diffusion of vesicles in the
absence and presence of unlabeled Va-HC added to the
0.0003 0.0004 0.0005 external vesicle compartment. The diffusion coefficient of a
'C] (M) sphere is related to its hydrodynamic radius. When Va-HC
was added to POPC SUVs, the hydrodynamic vesicle di-
ameter was observed to increase in a saturable fashion from
an initial value of 364 A to a saturation value of 505 A (Fig.
C 8 C). If Va-HC were closely packed on the vesicle surface
(density = 1.37 g/ml), this change in diameter would cor-
respond to one protein bound per 29 lipid molecules in a
vesicle (Pei et al., 1992).
The data obtained from all three experiments were ana-
lyzed together by a global nonlinear regression procedure
using ScOP (see Experimental Procedures) to obtain the
empirical parameters describing binding of factor Va-heavy
2 3 4 chain to neutral lipid membranes (Kd 0.30 + 0.02 ,uM;
;pholipid (w/w) stoichiometry 101 + 33). We have reported (Koppaka
and Lentz, 1996) that whole factor Va also binds to neutral
chain to phospholipid vesicles. phospholipid membranes, but with a somewhat larger Kd
POPC SUVs on the fluorescence (-3.0 ,M) and stoichiometry (-200 phospholipids/Va).
anisotropy of 0.2 jLM fluorescein-labeled factor Va heavy chain in 20 mM
TES, 150 mM NaCl, 5 mM CaC12, pH 7.5 (-); in the same buffer also
containing 25 mM sodium EDTA (0); and in buffer containing 400 mM
NaCl (A). The inset shows the effect of adding unlabeled Va-HC to a
sample containing 0.2 ,uM fluorescein-labeled Va-HC and 70.5 AuM POPC
SUVs in standard buffer. (B) Quenching of fluorescein-labeled factor Va
heavy chain fluorescence at 520 nm (0.3 ,uM in 20 mM TES, 150 mM
NaCl, 5 mM CaCl2, pH 7.5) due to fluorescence resonance energy transfer
was monitored as a function of increasing concentrations of Rh-PE/POPC
(1/99) SUVs. FD and FDA are the fluorescence intensities of fluorescein-Va
heavy chain in the absence and presence of Rh-PE acceptor. (C) Increase
in the mean hydrodynamic diameter of POPC SUVs (0.2 mM lipid) upon
the addition of unlabeled Va-HC, as determined by QELS. The curves
drawn through the binding isotherms were obtained by square residual
minimization performed globally on all data sets obtained in a common
buffer, using the SCoP package, as described in Experimental Methods.
teraction was not altered significantly by the absence of free
Ca2+ (Kd = 0.6 ,M, I/i = 133 lipids/bound protein) or by
high salt (Kd = 0.3 ,uM, I/i = 115 lipids/bound protein).
DISCUSSION
With respect to our two original objectives, several conclu-
sions are supported by the results presented here. First, with
respect to the behavior of the two forms of factor Va
containing the two light chain species,
1. The apparent values of Kd for membrane binding of
bovine factor Va reconstituted with either the 72,000 or the
74,000 MW form of the light chain are only slightly differ-
ent and are dependent on the concentration of calcium and
on lipid chain unsaturation.
2. The two forms of factor Va seem to undergo different
conformational changes when bound to a membrane at 5
mM Ca2+ but not at 2 mM Ca2 .
3. The activities of prothrombinase assembled with these
two forms of factor Va differ slightly, probably because of
different interactions between the enzyme and the cofactor.
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Second, with regard to the influence of factor Va and
its heavy and light chains on lipid packing and lateral
rearrangement,
1. Neither factor Va nor its light and heavy chains induce
detectable lipid demixing (lipid domains) within mem-
branes containing mixtures of acidic and neutral lipids.
2. Factor Va and factor Va-heavy chain binding favors
increased lateral lipid packing density in a fluid membrane,
especially one containing only neutral lipids.
3. Both factor Va and factor Va-heavy chain interact in a
reversible, Ca2+-independent fashion with neutral lipid
membranes.
These conclusions will be discussed in order.
Behavior of the two forms of factor Va
Binding
The light chain of bovine factor Va has always appeared as
a doublet on SDS gels in all of our preparations. This light
chain doublet has been reported previously by Nesheim et
al. (1984) and Guinto and Esmon (1984), and more recently
by Odegaard and Mann (1987). Because the two light chain
forms of factor Va differ in their carboxyl-terminal C2
segment (Odegaard and Mann, 1987; Ortel et al., 1992), and
because the C2 segment is responsible for the binding of
factor Va to the membrane surface (Ortel et al. (1992), it
might be expected that the two forms of light chain would
produce bovine factor Va species differing in their mem-
brane-binding properties. According to our direct binding
experiments (Table 1), bovine factor Va composed of the
72,000 MW light chain binds only about three times tighter
than the 74,000 MW form. In contrast, the two forms of
human factor Va are reported to bind very differently (Kd
values differ by -45-fold) to supported planar membranes
composed of 20/80 DOPS/DOPC at 5 mM Ca2+ (Rosing et
al., 1993). There are at least two possible reasons for this
difference between our observations and those of Rosing et
al. (1993). First, the two forms of factor Va may well behave
differently in the human as opposed to the bovine species.
Second, sonicated phospholipid vesicles (used here) proba-
bly present a membrane structure very different from that
presented by a supported planar bilayer (used by Rosing et
al.). Neither possibility can be ruled out, and both may
contribute to the differences seen between our results and
those of Rosing et al. (1993).
Conformations on a membrane
The binding of factor Va to membranes is a kinetically
complex, multistep process in which an initial rapid asso-
ciation is followed by a slower phase yielding higher affin-
ity binding (Bardelle et al., 1993). We have reported
(Cutsforth et al., 1996) that, if the binding of pyrene-labeled
factor Va with membranes were modeled thermodynami-
cally in terms of a two-process binding mechanism, one
independent adsorption to a membrane surface, whereas the
second process would involve the specific association of
acidic phospholipids with a limited number of sites on the
protein. Of particular interest was the observation that the
segmental flexibility of the pyrene-labeled portion of the
protein, as reported by fluorescence anisotropy, varied with
the type and amount of acidic lipid incorporated into the
bound membranes. This suggested that formation of a factor
Va-membrane complex might involve acidic-lipid-depen-
dent protein conformational changes. The results presented
here indicate that the segmental flexibilities and thus the
conformations of factor Va containing the 72,000 MW and
the 74,000 MW light chain are different at 5 mM Ca21
(Arsat values in Table 1). This might help explain the slight
differences in apparent binding affinities and activities of
these two forms of the prothrombinase cofactor.
Activity
Under both experimental conditions considered (limiting
factor Xa or limiting factor Va), maximum activity of the
prothrombinase complex was observed at micromolar con-
centrations of phospholipid (Fig. 2). In addition, there was
very little difference in the activities of the two forms of
factor Va within the rising portion of our lipid titration
curves (Fig. 2, A and B). Because the rising portion of such
a phospholipid response curve reflects mainly the mem-
brane binding of factor Va and the membrane assembly of
the prothrombinase (Powers and Lentz, 1993), the similarity
of the lipid response curves for the two forms of factor Va
implies very similar membrane binding properties for these
two species. This is consistent with the similar Kd values
measured by fluorescence techniques at the 5 mM Ca2+
concentration used in kinetic measurements (Table 1). Thus
the conclusion reached by Rosing et al. (1993) that "the
large [membrane] affinity difference likely explains the
different cofactor activities" appears not to apply to bovine
factor Va. The main difference between the lipid response
curves for the two bovine factor Va forms was the higher
activity observed for the 72,000 MW form at high lipid
concentration, especially in an assay system in which factor
Xa was limiting (Fig. 2 B). This portion of the lipid-response
curve reflects competition between free lipid and mem-
brane-bound factor Va for factor Xa (Powers and Lentz,
1993). Because the membrane affinities of the two forms of
bovine factor Va were quite similar, our data suggest that the
72,000MW form of light chain may interact more favorably
with factor Xa than does the 74,000 MW form, thereby
explaining the difference in the cofactor activities of the two
forms of bovine factor Va.
Membrane changes associated with factor
V. binding
Lipid packing and lipid domains
It has often been suggested that the binding site for the
process would involve a moderately strong acidic-lipid-
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components of the prothrombinase complex, including fac-
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tor Va, consists of a membrane patch or "lateral domain"
rich in acidic lipids (Lim et al., 1977; Dombrose et al., 1979;
Mayer and Nelsestuen, 1981, 1983). We have suggested
elsewhere that this is not the case for prothrombin and factor
Xa (Cutsforth et al., 1989; Tendian and Lentz, 1990), and
the data presented here indicate that this is also not the case
for factor Va. Phase diagrams (not shown) for DMPS/
DMPC or DC15PG/DMPC vesicles in the absence and pres-
ence of either factor Va or its components were constructed
from data such as those illustrated in Figs. 6 and 7, as
described by Tendian and Lentz (1990). The shapes of these
phase diagrams in the presence or absence of protein indi-
cated that the lateral mixing of neutral and acidic lipids was
probably close to ideal under both circumstances but, at any
rate, was not altered by protein binding. Formation of pro-
tein-induced acidic-lipid-rich domains is not consistent with
these observations (Tendian and Lentz, 1990). Consistent
with these results, our recent analysis of bovine factor Va
binding data indicates that a very few, rather than a large
pool, of acidic lipid molecules are involved in membrane
binding (Cutsforth et al., 1996).
Although binding of factor Va to DMPS- or DC15PG-
containing vesicles seems not to induce any lateral rear-
rangement of acidic lipids into pools or domains, it is clear
that it does induce a change in membrane order, as revealed
by a change in the DPH fluorescence anisotropy (Table 2).
A protein-induced increase in membrane order can result
from penetration of the bilayer by protein, leading to a
reduction of free volume within the bilayer. A number of
studies have suggested hydrophobic penetration as one
mechanism of factor Va binding (Krieg et al., 1987; Kalafa-
tis et al., 1990, 1994; Ortel et al., 1992; Lecompte et al.,
1994). Alternatively, the observed decrease in fluorescence
anisotropy could reflect any other event leading to an in-
crease in the lateral packing of lipids in the bilayer (Tendian
and Lentz, 1990). For this reason, our observation of a
factor Va-induced increase in fluorescence anisotropy is
consistent with but cannot be taken as proof of hydrophobic
penetration of the bilayer.
The effects of factor Va or its heavy chain on lipid order
was greatest for neutral lipid membranes free of acidic
lipids (Table 2). We have shown recently that factor Va
interacts with neutral lipid membranes (Koppaka and Lentz,
1996). Our present results extend our earlier report of a
factor Va interaction with neutral lipid membranes, suggest-
ing that this interaction probably involves some contribution
from the heavy chain component of factor Va' as discussed
below.
Role of heavy chain in membrane association
The binding experiments illustrated in Fig. 8 directly con-
firm that factor Va heavy chain binds to neutral lipid mem-
branes with an affinity comparable to, indeed, somewhat
greater than, that of intact factor Va. This implies that the
heavy chain accounts for a significant portion of the free
membrane. This view is supported by the observation that
the membrane order within neutral DMPC membranes was
altered to a comparable extent in the presence of either
whole factor Va or its heavy chain, but not in the presence
of light chain (compare anisotropy changes for Va, Va-LC,
and Va-HC in Table 2).
It can be argued that the apparent association of factor Va
heavy chain with neutral lipid membranes is due to impu-
rities in our heavy chain preparations. Such a hypothesis can
never be fully refuted, because completely pure prepara-
tions of bovine factor Va and factor Va components have
never been reported. However, we believe for three reasons
that this hypothesis is unlikely. First, the major impurity in
factor Va and Va-HC is usually a -55-kDa component seen
with SDS-PAGE. No fluorescence at -55 kDa was detect-
able with SDS-PAGE of labeled Va heavy chain. Thus the
experiments that quantitate factor Va heavy chain binding
using labeled factor Va heavy chain are not likely to be
severely affected by the major impurity in factor Va heavy
chain preparations. Because binding experiments with la-
beled and unlabeled Va-HC were consistent with the same
set of binding parameters, it is also unlikely that unlabeled
Va-HC binding is much affected by impurities. Second,
light chain impurities in heavy chain preparations cannot
account for the effects of heavy chain on membrane packing
(Table 2), because purified light chain had no effect on DPH
anisotropy. Finally, it might be argued that factor Va could
reassemble in the presence of 5 mM Ca2 , using the very
small contamination (<5% by SDS-PAGE) of light chain in
our heavy chain preparations, and that reassembled factor
Va might be responsible for the effects that we see. If this
were the case, we would expect the apparent Kd for heavy
chain binding to neutral lipid membranes to be equal to that
for factor Va binding (3 ,M; Koppaka and Lentz, 1996)
divided by the mol fraction contamination of light chain in
our heavy chain preparation. In fact, the opposite is true; the
estimated Kd for heavy chain binding to neutral lipid mem-
branes (0.37 ,M) is less than that for factor Va binding. In
addition, the apparent binding parameters for Va-HC to
POPC SUVs in the presence and absence of Ca21 were not
significantly different (Fig. 8 A). Because Ca2+ is necessary
for the reconstitution of factor Va from its heavy and light
chains, this rules out reassembled Va impurity as a cause of
our results. These comments argue forcefully against the
impurity hypothesis.
Our observation of factor Va heavy chain binding is
certainly surprising, because it has been fairly well accepted
that factor Va light chain largely accounts for membrane
binding (Higgins and Mann, 1983; Tracy and Mann, 1983;
Pusey and Nelsestuen, 1984; Krishnaswamy and Mann,
1988). However, all of these papers report the importance of
light chain to factor Va-membrane association, but none
provide direct evidence against a role for the heavy chain.
Kalafatis et al. (1994) have reported that both factor Va
heavy and light chains incorporate approximately equimolar
levels of a photoactive label, 1-azidopyrene, in the absence
energy driving association of factor Va with a neutral lipid
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of a membrane surface. However, in the presence of 100%
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POPC membranes, factor Va showed an approximately
threefold increase in labeling of the light chain and a two-
fold increase on the heavy chain. Earlier results of Krieg et
al. (1987), using another photoactivatable reagent, adaman-
tane diazirine, also showed similar label incorporation into
both heavy and light chain in the presence of neutral lipid
membranes. In both instances, labeling of heavy chain was
roughly half that of light chain for factor Va binding to
membranes containing acidic lipids. Although Kalafatis et
al. (1994) and Krieg et al. (1987) interpreted their observa-
tions to mean that heavy chain is not involved in the
interaction with membranes, their data are, in fact, not
inconsistent with our observation that Va-HC does bind to
neutral lipid membranes.
We show that both whole factor Va and the factor Va
heavy chain bind to and perturb the packing of neutral lipid
membranes, whereas the light chain alone did not alter lipid
packing. Furthermore, high salt concentration had little ef-
fect on the interaction of Va-HC with POPC SUVs, sug-
gesting that the interaction is not ionic in nature. This and
the Va-HC-induced increase in packing order suggest that
the interaction of Va-HC with a neutral lipid bilayer is at
least partially hydrophobic in nature. The perturbation of
membrane packing order by factor Va or its heavy chain was
less dramatic for membranes containing acidic lipids (Table
2). We suggest that heavy chain contributes to the acidic-
lipid-independent contribution to factor Va membrane bind-
ing, at least in part through a partial penetration into the
membrane hydrophobic core, but that the relative magni-
tudes of this contribution and of the acidic-lipid-dependent
contribution depend on membrane acidic lipid content, as
our previous analysis of factor Va binding data has indicated
(Cutsforth et al., 1996).
It should be noted that our observations do not imply that
an acidic-lipid-independent association site does not exist in
the light chain of factor Va. Indeed, it is known that the A3
domain of bovine factor V, which comprises the Mr 30,000
fragment of the light chain, has two hydrophobic segments
of amino acids that could potentially and probably do in-
teract with a phospholipid vesicle (Kalafatis et al., 1990,
1994). However, there are known to be highly homologous
hydrophobic regions in the Al and A2 domains of the heavy
chain (Jenny et al., 1987), which could account for the
interaction of factor Va heavy chain with neutral phospho-
lipid membranes. It may be that interaction of these regions
of the heavy chain with a membrane can occur in the
absence of acidic lipid, whereas membrane interaction with
the light chain hydrophobic regions may require occupancy
of specific acidic lipid sites or assembly of whole factor Va.
Indeed, our previous results have suggested that the inter-
actions of the various sites on factor Va with a membrane
are highly interdependent and that occupancy of one site
probably causes conformational changes that alter the mem-
brane affinity of other sites (Cutsforth et al., 1996).
Finally, it might be argued that the interaction of factor
Va or its heavy chain with neutral membranes is not phys-
iologically significant, because it is much weaker than that
observed for intact factor Va with acidic-lipid-containing
membranes (Kd 2 nM; Cutsforth et al., 1996). Whereas
the major free energy of factor Va binding to a membrane
may well be contributed by the light chain, we argue that
less energetic interactions of the heavy chain with the mem-
brane may contribute significantly to the configuration and
functioning of the whole molecule on a membrane. Because
a clear mechanistic role for factor Va in prothrombin acti-
vation has not been established, it is difficult to judge the
relevance of any component of the total factor Va-mem-
brane interaction to the function of this critical blood coag-
ulation cofactor. However, Gerads et al. (1990) and Govers-
Riemslag et al. (1994) observed prothrombin activation on
dioleoylphosphatidylcholine membranes, but only in the
presence of factor Va, thus providing indirect support for a
functionally significant interaction of factor Va with neutral
lipid membranes.
A model for factor Va-membrane complex formation
Fig. 9 presents a hypothetical model that summarizes our
present understanding of the complexities of factor Va as-
sociation with a procoagulant membrane. The model envi-
sions factor Va binding as involving acidic-lipid-indepen-
dent adsorption to a membrane surface. The results
presented here suggest that the factor Va heavy chain con-
tributes to this. Based on the results of Cutsforth et al.
(1996) from pyrene-labeled factor Va and on the results
presented in this study from fluorescein-labeled factor Va,
this model proposes a conformational change of factor Va
:,' .:
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membrane surface
K C(
Specific i
binding of
_ PS to LC sites
Lolw PS content
He;f
factor Va
*
righ PS content
FIGURE 9 Model for molecular events associated with membrane bind-
ing of factor Va. Binding appears to involve both acidic lipid sites and
acidic-lipid-independent modes of association (represented by protein "fin-
gers" penetrating the bilayer). The acidic-lipid-independent association of
factor Va with neutral membranes suggested by our observations appears to
involve to some extent the heavy chain portion (HC) of factor Va. Specific
binding of acidic lipids (a) to sites on factor Va (Cutsforth et al., 1996)
probably involves the light chain portion (LC) of the molecule. It appears
that the binding affinities at different sites are altered by the occupancy of
other sites by means of ligand-induced protein conformational changes.
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on binding to a surface. The model shows a change in both
the heavy and light chains, but there is no way to locate the
change in any particular region of factor Va from our data.
We know at this point only that a pyrene probe or a
fluorescein probe located on the heavy chain is altered in its
segmental motion by binding. This result could be due to
direct interaction between the heavy chain in factor Va and
the membrane, although changes in heavy chain conforma-
tion could also result from altered interactions between
heavy and light chains within factor Va bound to a mem-
brane. More data will be needed to locate and confirm a
membrane-induced conformational change. What is clear
from our membrane phase behavior data and from the
thermodynamic binding analysis of Cutsforth et al. (1996) is
that factor Va binds only a limited number of acidic lipid
molecules rather than gathering a large domain of these
molecules. In addition, the conformational states of factor
Va on acidic-lipid-rich versus acidic-lipid-poor membranes
appear to be different (Cutsforth et al., 1996), as illustrated
in Fig. 9. The conformation suggested in the figure for
acidic-lipid-rich membranes is drawn to be consistent with
the structural data of Stoylova et al. (1994) and with the
small limiting binding stoichiometry reported by Cutsforth
et al. (1996). The hydrophobic penetration of the heavy
chain segment is suggested but not clearly established by
the ionic-strength-independence of our Va-HC binding data,
as well as by the common effect of Va-HC and Va on the
fluorescence anisotropy of DPH in DMPC membranes.
The purposes of the model shown in Fig. 9 are to help
focus the issues involved in factor Va membrane binding
and to stimulate further experiments. Many issues remain to
be resolved, such as locating and defining the conforma-
tional change(s) associated with membrane binding, quan-
titating the interaction of heavy chain with membranes
containing acidic lipids, establishing the role of Ca2+ in
complex formation, and determining whether the suspected
conformational changes have consequences for the func-
tioning of factor Va.
We thank Drs. Charles T. Esmon and Sriram Krishnaswamy for their
helpful suggestions during the purification of factor Va.
This work was supported by the U.S. Public Health Service (HL45916).
REFERENCES
Bardelle, C., B. Furie, B. C. Furie, and G. E. Gilbert. 1993. Membrane
binding kinetics of factor VIII indicate a complex binding process.
J. Biol. Chem. 268:8815-8824.
Bloom, J. W., M. E. Nesheim, and K. G. Mann. 1979. Phospholipid
binding properties of bovine factor V and factor Va. Biochemistry.
20:4419-4425.
Chen, P. S., Jr., T. Y. Toribara, and H. Warner. 1956. Microdetermination
of phosphorous. Anal. Chem. 28:1756-1758.
Cutsforth, G. A., V. Koppaka, S. Krishnaswamy, J. R. Wu, K. G. Mann,
and B. R. Lentz. 1996. Insights into the complex association of bovine
factor Va with acidic-lipid containing synthetic membranes. Biophys. J.
70:2938-2949.
Cutsforth, G. A., R. N. Whitaker, J. Hermans, and B. R. Lentz. 1989. A
new model to describe extrinsic protein binding to phospholipid mem-
branes of varying composition: application to human prothrombin and
factor X. Biochemistry. 28:7453-7459.
Dombrose, F. A., S. N. Gitel, K. Zawalich, and C. M. Jackson. 1979. The
association of bovine prothrombin fragment 1 with phospholipid. J. Biol.
Chem. 254:5027-5040.
Donovan, J. W. 1969. In Physical Principles and Techniques of Protein
Chemistry, Part A. S. J. Leach, editor. Academic Press, New York.
164-165.
Esmon, C. T. 1979. The subunit structure of thrombin-activated factor Va.
J. Biol. Chem. 254:964-973.
Foster, W. B., M. E. Nesheim, and K. G. Mann. 1984. Factor Xa activation
of factor V. J. Biol. Chem. 258:13970-13977.
Gerads, I., J. W. P. Govers-Riemslag, G. Tans, R. F. A. Zwaal, and J.
Rosing. 1990. Prothrombin activation on membranes with anionic lipids
containing phosphate, sulfate, and/or carboxyl groups. Biochemistry.
29:7967-7974.
Giesen, P. L. A., G. M. Willems, H. C. Hemker, and W. T. Hermans. 1991.
Membrane-mediated assembly of the prothrombinase complex. J. Bio.
Chem. 266:18720-18725.
Govers-Riemslag, J. W. P., M. P. Janssen, and J. Rosing. 1994. Prothrom-
bin activation on dioleoylphosphatidylcholine membranes. Eur. J. Bio-
chem. 220:131-138.
Guinto, E. R., and C. T. Esmon. 1984. Loss of prothrombin and factor
Xa-factor Va interactions upon inactivation of factor Va by activated
protein C. J. Biol. Chem. 259:13986-13992.
Higgins, D. L., and K. G. Mann. 1983. The interaction of bovine factor V
and factor V-derived peptides with phospholipid vesicles. J. Biol. Chem.
258:6503-6508.
Isaacs, B. S., E. J. Husten, C. T. Esmon, and A. E. Johnson. 1986. A
domain of membrane-bound blood coagulation factor Va is located far
from the phospholipid surface. A fluorescence energy transfer measure-
ment. Biochemistry. 25:4958-4969.
Jenny, R. J., D. D. Pittman, J. J. Toole, R. W. Kriz, R. A. Aldape, R. M.
Hewick, R. J. Kaufman, and K. G. Mann. 1987. Complete cDNA and
derived amino acid sequence of human factor V. Proc. Natl. Acad. Sci.
USA. 84:4846-4850.
Jesty, J., and Y. Nemerson. 1976. The activation of bovine coagulation
factor X. Methods Enzymol. 45:95-107.
Kalafatis, M., R. J. Jenny, and K. G. Mann. 1990. Identification and
characterization of a phospholipid-binding site on bovine factor Va.
J. Biol. Chem. 265:21580-21589.
Kalafatis, M., M. D. Rand, and K. G. Mann. 1994. Factor Va-membrane
interaction is mediated by two regions located on the light chain of the
cofactor. Biochemistry. 33:486-493.
Kane, W. H., and P. W. Majerus. 1982. The interaction of human coagu-
lation factor Va with platelets. J. Biol. Chem. 257:3963-3969.
Kop, J. M. M., G. M. Willems, and W. T. Hermens. 1989. Binding of blood
coagulation factor V to planar phospholipid double layers. J. Colloid
Interface Sci. 133:369-376.
Koppaka, V., and B. R. Lentz. 1996. Binding of bovine factor Va to
phosphatidylcholine membranes. Biophys. J. 70:2930-2937.
Krieg, U. C., B. S. Isaacs, S. S. Yemul, C. T. Esmon, H. Bayley, and A. E.
Johnson. 1987. Interaction of blood coagulation factor Va with phos-
pholipid vesicles examined by using lipophilic photoreagents. Biochem-
istry. 26:103-109.
Krishnaswamy, S., and K. G. Mann. 1988. The binding of factor Va to
phospholipid vesicles. J. Biol. Chem. 263:5714-5723.
Krishnaswamy, S., G. D. Russell, and K. G. Mann. 1989. The reassociation
of factor Va from its isolated subunits. J. Biol. Chem. 264:3160-3168.
Krishnaswamy, S., E. B. Williams, and K. G. Mann. 1986. The binding of
activated protein C to factors V and Va. J. Biol. Chem. 261:9684-9693.
Lecompte, M. F., G. Bouix, and K. G. Mann. 1994. Electrostatic and
hydrophobic interactions are involved in factor Va binding to mem-
branes containing acidic phospholipids. J. Biol. Chem. 269:1905-1910.
Lentz, B. R., Y. Barenholz, and T. E. Thompson. 1976a. Fluorescence
depolarization studies of phase transitions and fluidity in phospholipid
bilayers. 1. Single component phosphatidylcholine liposomes. Biochem-
istry. 15:4521-4529.
Lentz, B. R., Y. Barenholz, and T. E. Thompson. 1976b. Fluorescence
depolarization studies of phase transitions and fluidity in phospholipid
2652 Biophysical Journal Volume 73 November 1997
bilayers. 2. Two-component phosphatidylcholine liposomes. Biochem-
istry. 15:4529-4537.
Lentz, B. R., S. Madden, and D. R. Alford. 1982. Transbilayer redistribu-
tion of phosphatidylglycerol in small, unilamellar vesicles induced by
specific divalent cations. Biochemistry. 21:6799-6807.
Lentz, B. R., G. F. McIntyre, D. J. Parks, J. C. Yates, and D. Massenburg.
1992. Bilayer curvature and certain amphipaths promote poly(ethylene
glycol)-induced fusion of dipalmitoylphosphatidylcholine unilamellar
vesicles. Biochemistry. 31:2643-2653.
Lentz, B. R., C.-M. Zhou, and J. R. Wu. 1994. Phosphatidylserine-
containing membranes alter the thermal stability of prothrombin's cat-
alytic domain: a differential scanning calorimetric study. Biochemistry.
33:5460-5468.
Lim, T. K., V. A. Bloomfield, and G. L. Nelsestuen. 1977. Structure of the
prothrombin- and blood clotting factor X-membrane complexes. Bio-
chemistry. 16:4177-4181.
Mann, K. G. 1976. Blood clotting enzymes [13]: prothrombin. Methods
Enzymol. 45:123-156.
Mann, K. G., J. Elion, R. T. Butkowski, M. Downing, and M. E. Nesheim.
1981. Prothrombin. Methods Enzymol. 80:286-302.
Mayer, L. D., and G. L. Nelsestuen. 1981. Calcium- and prothrombin-
induced lateral phase separation in membranes. Biochemistry. 20:
2457-2463.
Mayer, L. D., and G. L. Nelsestuen. 1983. Membrane lateral phase sepa-
ration induced by proteins of the prothrombinase complex. Biochim.
Biophys. Acta. 734:48-53.
Mosesson, M. W., W. R. Church, J. P. DiOrio, S. Krishnaswamy, K. G.
Mann, J. P. Hainfeld, and J. S. Wall. 1990. Stuctural model of factors V
and Va based on scanning transmission electron microscope images and
MSS analysis. J. Biol. Chem. 265:8863-8868.
Nesheim, M. E., W. B. Foster, R. Hewick, and K. G. Mann. 1984.
Characterization of factor V activation intermediates. J. Biol. Chem.
259:3187-3196.
Nesheim, M. E., J. A. Katzmann, P. B. Tracy, and K. G. Mann. 1981.
Factor V. Methods Enzymol. 80:249-274.
Nesheim, M. E., and K. G. Mann. 1979. Thrombin-catalyzed activation of
single chain bovine factor V. J. Biol. Chem 254:1326-1334.
Nesheim, M. E., K. Myrmel, L. Hibbard, and K. G. Mann. 1979a. Isolation
and characterization of single chain bovine factor V. J. Biol. Chem.
254:508-517.
Nesheim, M. E., F. G. Prendergast, and K. G. Mann. 1979b. Interactions of
a fluorescent active-site-directed inhibitor of thrombin: dansylarginine
N-(3-ethyl-1,5-pentanediyl)amide. Biochemistry. 18:996-1003.
Odegaard, B., and K. G. Mann. 1987. Proteolysis of factor Va by factor Xa
and activated protein C. J. Biol. Chem. 262:11233-11238.
Ortel, T., D. Devore-Carter, M. Quinn-Allen, and W. Kane. 1992. Deletion
analysis of recombinant human factor V. J. Biol. Chem. 267:
4189-4198.
Ortel, T. L., M. A. Quinn-Allen, F. G. Keller, J. A. Peterson, D. Larocca,
and W. H. Kane. 1994. Localization of functionally important epitopes
within the second C-type domain of coagulation factor V using recom-
binant chimeras. J. Biol. Chem. 269:15898-15905.
Pei, G., T. M. Laue, A. Aulabaugh, D. M. Folks, and B. R. Lentz. 1992.
Structural comparisons of meizothrombin and its precursor prothrombin
in the presence or absence of procoagulant membranes. Biochemistry.
31:6990-6996.
Pei, G., D. D. Powers, and B. R. Lentz. 1993. Specific contribution of
different phospholipid surfaces to the activation of prothrombin by the
fully assembled prothrombinase. J. Biol. Chem. 268:3226-3233.
Powers, D. D., and B. R. Lentz. 1993. Simulation of prothrombin prote-
olysis by the full prothrombinase assembled on varied phospholipid
surfaces. J. Biol. Chem. 268:3234-3237.
Pusey, M. L., L. D. Mayer, G. J. Wei, V. A. Bloomfield, and G. L.
Nelsestuen. 1982. Kinetic and hydrodynamic analysis of blood clotting
factor V. Membrane binding. Biochemistry. 21:5262-5269.
Pusey, M. L., and G. L. Nelsestuen. 1984. Membrane binding properties of
blood coagulation factor V and derived peptides. Biochemistry. 23:
6202-6210.
Rosing, J., H. M. Bakker, M. C. L. G. D. Thomassen, H. C. Hemker, and
G. Tans. 1993. Characterization of two forms of human factor Va with
different cofactor activities. J. Biol. Chem. 268:21130-21136.
Stoylova, S., K. G. Mann, and A. Brisson. 1994. Structure of membrane-
bound human factor Va. FEBS Lett. 351:330-334.
Tendian, S. W., and B. R. Lentz. 1990. Evaluation of membrane phase
behavior as a tool to detect extrinsic protein-induced domain formation:
binding of prothrombin to phosphatidylserine/phosphatidylcholine ves-
icles. Biochemistry. 29:6720-6729.
Tracy, P. B., and K. G. Mann. 1983. Prothrombinase complex assembly on
the platelet surface is mediated through the 74,000-dalton component of
factor Va. Proc. Natl. Acad. Sci. USA. 80:2380-2384.
Tracy, P. B., M. E. Nesheim, and K. G. Mann. 1981. Co-ordinate binding
of factor Va and factor Xa to the unstimulated platelet. J. Biol. Chem.
256:743-751.
